慢性阻塞性肺疾病（COPD）的药物治疗管理。基于真实世界证据的研究 - 第 2 部分。
Pharmacological Management of Chronic Obstructive Lung Disease (COPD). Evidence from a Real-World Perspective - Part 2.
机构信息
Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele Pisana, Via di Valcannuta, 247, I-00166 Rome, Italy.
Unit of Pulmonary Rehabilitation, IRCCS San Raffaele Pisana, Via della Pisana, 235, 00163 Rome, Italy.
出版信息
Curr Med Chem. 2019;26(10):1734-1745. doi: 10.2174/0929867325666181031101128.
BACKGROUND
We report a comprehensive overview of current COPD therapies from a real-world experience.
OBJECTIVE
Critically review the opportunities and the challenges occurring in the real-world treatment of COPD.
METHODS
This is a review that also report results from COPD patients treated with standardized therapy including pulmonary rehabilitation (Real World Data - RWD).
CONCLUSION
Comprehensive assessment of COPD management requires strategies able to evaluate efficacy and usefulness in a real-world population, that take into account the interaction between experience and academic training, research, adherence to guidelines and judgments in order to plan the appropriate and optimum use of available strategies.
背景
我们从实际经验报告了当前 COPD 治疗的综合概述。
目的
从实际治疗 COPD 的角度，严格审查现有的机遇和挑战。
方法
这是一篇综述，还报告了接受标准化治疗（包括肺康复）的 COPD 患者的结果。
结论
全面评估 COPD 管理需要能够评估真实人群中疗效和有用性的策略，这些策略需要考虑经验与学术培训、研究、对指南的依从性和判断之间的相互作用，以便为现有策略的合理和优化使用做好计划。
Zotero 插件